InterCure (INCR) Short Interest Ratio & Short Volume $1.55 -0.02 (-1.52%) Closing price 03:58 PM EasternExtended Trading$1.48 -0.07 (-4.45%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock InterCure Short Interest DataInterCure (INCR) has a short interest of 26,000 shares, representing 0.10% of the float (the number of shares available for trading by the public). This marks a -23.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 33,862 shares to cover all short positions.Current Short Interest26,000 sharesPrevious Short Interest34,100 sharesChange Vs. Previous Month-23.75%Dollar Volume Sold Short$34,450.00Short Interest Ratio1.2 Days to CoverLast Record DateApril 15, 2025Outstanding Shares45,573,000 sharesFloat Size27,160,000 sharesShort Percent of Float0.10%Today's Trading Volume23,968 sharesAverage Trading Volume33,862 sharesToday's Volume Vs. Average71% Short Selling InterCure? Sign up to receive the latest short interest report for InterCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINCR Short Interest Over TimeINCR Days to Cover Over TimeINCR Percentage of Float Shorted Over Time InterCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202526,000 shares $34,450.00 -23.8%0.1%1.2 $1.33 3/31/202534,100 shares $47,740.00 +24.5%0.1%1.6 $1.40 3/15/202527,400 shares $44,388.00 -1.8%0.1%1 $1.62 2/28/202527,900 shares $43,803.00 +1.8%0.1%0.9 $1.57 2/15/202527,400 shares $44,388.00 -33.3%0.1%0.8 $1.62 1/31/202541,100 shares $68,226.00 -4.6%0.2%1.1 $1.66 1/15/202543,100 shares $73,701.00 -7.3%0.2%1.1 $1.71 12/31/202446,500 shares $73,935.00 +96.2%0.2%1.1 $1.59 12/15/202423,700 shares $31,215.27 -36.3%0.1%0.6 $1.32 11/30/202437,200 shares $49,476.00 +129.6%0.1%1.1 $1.33 Get the Latest News and Ratings for INCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. 11/15/202416,200 shares $18,954.00 +16.6%0.1%0.5 $1.17 10/31/202413,900 shares $23,769.00 -21.9%0.1%0.5 $1.71 10/15/202417,800 shares $32,312.34 -12.8%0.1%0.7 $1.82 9/30/202420,400 shares $41,004.00 +2.5%0.1%0.8 $2.01 9/15/202419,900 shares $39,402.00 -43.1%0.1%0.7 $1.98 8/31/202435,000 shares $79,450.00 +17.1%0.1%1.2 $2.27 8/15/202429,900 shares $56,212.00 +18.2%0.1%0.9 $1.88 7/31/202425,300 shares $55,407.00 -45.2%0.1%0.7 $2.19 7/15/202446,200 shares $110,418.00 -10.3%0.2%0.9 $2.39 6/30/202451,500 shares $103,515.00 -14.5%0.2%1 $2.01 6/15/202460,200 shares $142,072.00 -15.2%0.2%0.9 $2.36 5/31/202471,000 shares $209,450.00 +1.7%0.3%1 $2.95 5/15/202469,800 shares $228,944.00 +69.0%0.3%1 $3.28 4/30/202441,300 shares $120,596.00 -26.5%0.2%0.6 $2.92 4/15/202456,200 shares $137,690.00 -37.7%0.2%0.6 $2.45 3/31/202490,200 shares $244,442.00 -14.6%0.3%1 $2.71 3/15/2024105,600 shares $195,360.00 -23.7%0.4%1.3 $1.85 2/29/2024138,400 shares $271,264.00 +3.6%0.5%1.9 $1.96 2/15/2024133,600 shares $233,800.00 -31.7%0.5%1.9 $1.75 1/31/2024195,700 shares $230,926.00 -9.6%0.7%2.6 $1.18 1/15/2024216,400 shares $318,108.00 +7.3%0.8%4.3 $1.47 12/31/2023201,600 shares $260,023.68 -2.0%0.7%4.4 $1.29 12/15/2023205,600 shares $248,776.00 -4.6%0.8%4.7 $1.21 11/30/2023215,600 shares $263,032.00 +317.8%0.8%5 $1.22 11/15/202351,600 shares $65,532.00 +11.5%0.2%1.1 $1.27 10/31/202346,300 shares $46,763.00 +13.2%0.2%1.1 $1.01 10/15/202340,900 shares $53,579.00 +18.9%0.2%1 $1.31 9/30/202334,400 shares $54,008.00 -42.6%0.1%0.8 $1.57 9/15/202359,900 shares $101,231.00 +71.6%0.2%1.2 $1.69 8/31/202334,900 shares $56,189.00 +156.6%0.1%0.8 $1.61Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/15/202313,600 shares $20,808.00 -28.0%0.1%0.3 $1.53 7/31/202318,900 shares $30,051.00 -62.2%0.1%0.4 $1.59 7/15/202350,000 shares $82,000.00 +36.6%0.2%1.1 $1.64 6/30/202336,600 shares $62,220.00 -11.6%0.1%0.8 $1.70 6/15/202341,400 shares $88,182.00 +18.3%0.2%0.9 $2.13 5/31/202335,000 shares $67,900.00 -40.2%0.1%0.6 $1.94 5/15/202358,500 shares $150,930.00 +28.9%0.2%0.9 $2.58 4/30/202345,400 shares $105,782.00 -15.9%0.2%0.7 $2.33 4/15/202354,000 shares $120,960.00 -16.4%0.2%0.8 $2.24 3/31/202364,600 shares $131,784.00 -26.5%0.2%1 $2.04 3/15/202387,900 shares $169,647.00 +13.3%0.3%1.5 $1.93 2/28/202377,600 shares $191,672.00 +7.3%0.3%1.9 $2.47 2/15/202372,300 shares $245,820.00 -39.9%0.3%1.9 $3.40 1/31/2023120,200 shares $442,336.00 +71.2%0.4%3.9 $3.68 1/15/202370,200 shares $267,462.00 -12.6%0.3%2.7 $3.81 12/30/202280,300 shares $264,990.00 -13.4%0.3%3.5 $3.30 12/15/202292,700 shares $396,756.00 +1.0%0.3%3 $4.28 11/30/202291,800 shares $455,328.00 +71.6%0.3%2.4 $4.96 11/15/202253,500 shares $281,410.00 -40.3%0.2%1.2 $5.26 10/31/202289,600 shares $431,872.00 -5.5%0.3%1.3 $4.82 10/15/202294,800 shares $430,392.00 +5.1%0.4%1.4 $4.54 9/30/202290,200 shares $405,900.00 +58.5%0.3%1.3 $4.50 9/15/202256,900 shares $249,791.00 -31.5%0.2%0.9 $4.39 8/31/202283,000 shares $429,110.00 +14.6%0.3%1.5 $5.17 8/15/202272,400 shares $450,328.00 -9.1%0.3%1.4 $6.22 7/31/202279,600 shares $467,252.00 -6.9%0.3%1.4 $5.87 7/15/202285,500 shares $496,755.00 -5.6%0.3%1.5 $5.81 6/30/202290,600 shares $524,574.00 -10.5%0.3%1.6 $5.79 6/15/2022101,200 shares $587,972.00 -26.7%0.4%1.7 $5.81 5/31/2022138,000 shares $890,100.00 +60.8%0.5%2.2 $6.45 5/15/202285,800 shares $643,500.00 +288.2%0.3%1.3 $7.50 4/30/202222,100 shares $127,959.00 -20.5%0.1%0.3 $5.79 4/15/202227,800 shares $172,360.00 -44.2%0.1%0.4 $6.20 3/31/202249,800 shares $353,580.00 -58.6%0.2%0.7 $7.10 3/15/2022120,300 shares $771,123.00 -53.3%0.5%1.7 $6.41 2/28/2022257,600 shares $1.66 million -25.1%1.0%4 $6.46 2/15/2022343,800 shares $2.42 million +667.4%1.4%5.3 $7.05 1/31/202244,800 shares $275,968.00 -10.6%0.2%0.6 $6.16 1/15/202250,100 shares $331,161.00 -58.8%N/A0.7 $6.61 12/31/2021121,600 shares $787,968.00 No Change0.5%1.6 $6.48 INCR Short Interest - Frequently Asked Questions What is InterCure's current short interest? Short interest is the volume of InterCure shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 26,000 shares of INCR short. 0.10% of InterCure's shares are currently sold short. Learn More on InterCure's current short interest. What is a good short interest ratio for InterCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INCR shares currently have a short interest ratio of 1.0. Learn More on InterCure's short interest ratio. Which institutional investors are shorting InterCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of InterCure: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for InterCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of InterCure's floating shares are currently sold short. Is InterCure's short interest increasing or decreasing? InterCure saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 26,000 shares, a decrease of 23.8% from the previous total of 34,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is InterCure's float size? InterCure currently has issued a total of 45,573,000 shares. Some of InterCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. InterCure currently has a public float of 27,160,000 shares. How does InterCure's short interest compare to its competitors? 0.10% of InterCure's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InterCure: Astria Therapeutics, Inc. (6.79%), Aquestive Therapeutics, Inc. (11.75%), Aura Biosciences, Inc. (4.36%), Aurora Cannabis Inc. (9.05%), Compass Therapeutics, Inc. (9.30%), 2seventy bio, Inc. (7.96%), Terns Pharmaceuticals, Inc. (8.55%), Atea Pharmaceuticals, Inc. (4.42%), DBV Technologies S.A. (0.59%), Solid Biosciences Inc. (12.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short InterCure stock? Short selling INCR is an investing strategy that aims to generate trading profit from InterCure as its price is falling. INCR shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InterCure? A short squeeze for InterCure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INCR, which in turn drives the price of the stock up even further. How often is InterCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INCR, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ATXS Short Interest AQST Short Interest AURA Short Interest ACB Short Interest CMPX Short Interest TSVT Short Interest TERN Short Interest AVIR Short Interest DBVT Short Interest SLDB Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INCR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InterCure Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InterCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INCR Stock Free INCR Stock Alerts